A 663 New York Assembly · 2021 Regular Session

Requires certain manufacturers of prescription drugs to notify the drug utilization review board of the proposed increase of the wholesale acquisition cost of such prescription drugs

Summary

Requires certain manufacturers of prescription drugs to notify the drug utilization review board of the proposed increase of the wholesale acquisition cost of such prescription drugs.

Bill status in committee 1 of 4 stages cleared

Introduction

Jan 2021

Committee Review

Floor Vote

Governor

Introduced Jan 6, 2021 Last action May 19, 2022

Floor votes

How they voted

No floor votes recorded yet.

Full legislative history

Actions timeline

Total actions

Key actions

Committee

Amendments

May 19, 2022

Lower · Passed

PRINT NUMBER 663B

lower

May 19, 2022

Lower · Passed

AMEND AND RECOMMIT TO HEALTH

lower

May 6, 2022

Lower · Passed

PRINT NUMBER 663A

lower

May 6, 2022

Lower · Passed

AMEND (T) AND RECOMMIT TO HEALTH

lower

Jan 5, 2022

Committee

REFERRED TO HEALTH

lower

Jan 6, 2021

Committee

REFERRED TO HEALTH

lower

1 primary · 10 co-sponsors

Sponsors

Role

Legislator

Party

State

District